Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet

Mol Nutr Food Res. 2018 Oct;62(20):e1800331. doi: 10.1002/mnfr.201800331. Epub 2018 Aug 19.

Abstract

Scope: Galactomannan and citrus pectin are considered 'super fibers' known for altering gut microbiota composition and improving glucose and lipid metabolism. The study aims to investigate the fiber's effect on a nonalcoholic steatohepatitis (NASH) model.

Methods and results: Two feeding experiments are carried out using groups of 7-8 week-old male C57BL/6J mice. The diets used are based on a high cholesterol/cholate diet (HCD), such as a nutritional NASH model. Mice are fed a diet with or without 15% fiber-citrus pectin (HCD-CP) or galactomannan (HCD-G) together with the HCD (first experiment), which commenced 3 weeks prior to the HCD (second experiment). Liver damage is evaluated by histological and biochemical parameters. Galactomannan leads to lesser weight gain and improved glucose tolerance, but increased liver damage. This is shown by elevated levels of liver enzymes compared to that with HCD alone. Fibers induce higher steatosis, as evaluated by liver histology. This intriguing result is linked to various changes in the gut microbiota, such as elevated Proteobacteria levels in the galactomannan group, which are correlated with disturbed metabolism and dysbiosis.

Conclusions: In a NASH mouse model, galactomannan increases liver damage but improves glucose metabolism. Changes in the microbiota composition may answer this enigmatic observation.

Keywords: NASH; dietary fiber; glucose metabolism; gut microbiota; liver injury.

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Cholesterol / administration & dosage
  • Cholesterol / adverse effects
  • Diet, High-Fat / adverse effects*
  • Dietary Fiber / adverse effects
  • Disease Models, Animal
  • Fatty Acids, Volatile / metabolism
  • Galactose / analogs & derivatives
  • Gastrointestinal Contents / drug effects
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / genetics
  • Glucose Tolerance Test
  • Lipid Metabolism / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Mannans / adverse effects*
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / chemically induced*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology
  • Pectins / adverse effects*

Substances

  • Dietary Fiber
  • Fatty Acids, Volatile
  • Mannans
  • galactomannan
  • citrus pectin
  • Pectins
  • Cholesterol
  • Galactose